Patents by Inventor Oscar Sala
Oscar Sala has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11169158Abstract: The present invention provides methods and systems for the rapid determination of the intact mass of non-covalently associated antibody heavy chains (HC) and light chains (LC) which result from the attachment of drug conjugates to interchain cysteine residues. By analyzing the antibody-drug conjugate (ADC) using native desalting conditions, the intact-bivalent structure of the ADC, which ordinarily would decompose as a consequence of denaturing chromatographic conditions typically used for LCMS, is maintained. The mass of the desalted ADC is subsequently determined using desolvation and ionization ESI-MS conditions. The methods described herein provide for direct measurement of the intact mass of an ADC conjugated at interchain cysteine residues. The methods described herein also provide for the relative quantitation of the individual ADC species.Type: GrantFiled: March 19, 2018Date of Patent: November 9, 2021Assignee: Seagen Inc.Inventors: John Fay Valliere-Douglass, Oscar Salas
-
Publication number: 20180275137Abstract: The present invention provides methods and systems for the rapid determination of the intact mass of non-covalently associated antibody heavy chains (HC) and light chains (LC) which result from the attachment of drug conjugates to interchain cysteine residues. By analyzing the antibody-drug conjugate (ADC) using native desalting conditions, the intact-bivalent structure of the ADC, which ordinarily would decompose as a consequence of denaturing chromatographic conditions typically used for LCMS, is maintained. The mass of the desalted ADC is subsequently determined using desolvation and ionization ESI-MS conditions. The methods described herein provide for direct measurement of the intact mass of an ADC conjugated at interchain cysteine residues. The methods described herein also provide for the relative quantitation of the individual ADC species.Type: ApplicationFiled: March 19, 2018Publication date: September 27, 2018Inventors: John Fay VALLIERE-DOUGLASS, Oscar SALAS
-
Patent number: 9958455Abstract: The present invention provides methods and systems for the rapid determination of the intact mass of non-covalently associated antibody heavy chains (HC) and light chains (LC) which result from the attachment of drug conjugates to interchain cysteine residues. By analyzing the antibody-drug conjugate (ADC) using native desalting conditions, the intact-bivalent structure of the ADC, which ordinarily would decompose as a consequence of denaturing chromatographic conditions typically used for LCMS, is maintained. The mass of the desalted ADC is subsequently determined using desolvation and ionization ESI-MS conditions. The methods described herein provide for direct measurement of the intact mass of an ADC conjugated at interchain cysteine residues. The methods described herein also provide for the relative quantitation of the individual ADC species.Type: GrantFiled: September 27, 2012Date of Patent: May 1, 2018Assignee: Seattle Genetics, Inc.Inventors: John Fay Valliere-Douglass, Oscar Salas
-
Publication number: 20140242624Abstract: The present invention provides methods and systems for the rapid determination of the intact mass of non-covalently associated antibody heavy chains (HC) and light chains (LC) which result from the attachment of drug conjugates to interchain cysteine residues. By analyzing the antibody-drug conjugate (ADC) using native desalting conditions, the intact-bivalent structure of the ADC, which ordinarily would decompose as a consequence of denaturing chromatographic conditions typically used for LCMS, is maintained. The mass of the desalted ADC is subsequently determined using desolvation and ionization ESI-MS conditions. The methods described herein provide for direct measurement of the intact mass of an ADC conjugated at interchain cysteine residues. The methods described herein also provide for the relative quantitation of the individual ADC species.Type: ApplicationFiled: September 27, 2012Publication date: August 28, 2014Applicant: Seattle Genetics, Inc.Inventors: John Fay Valliere-Douglass, Oscar Salas
-
Patent number: 8138362Abstract: A method for extracting internal lipids from wool that is substantially free of lanolin, comprising the use of a fluid under supercritical conditions and an agent that can change the polarity of said fluid, selected from methanol and/or ethanol, is disclosed. According to the operating conditions described, the temperature is between 40° C. and 120° C., and the pressure is between 120 bars and 330 bars. The polarity-changing agent represents between 3% and 15% expressed as volume/volume. The inventive method can be used to obtain internal lipids from wool, one of the most significant components of which are ceramides, which can be used in compositions intended to protect human skin against environmental damage.Type: GrantFiled: February 27, 2008Date of Patent: March 20, 2012Assignee: Centro Technologico GaikerInventors: Ma Luisa Coderch Negra, Raquel Ramírez Mileo, Meritxell Martí Gelabert, José Luis Parra Juez, Iratxe Garay Peral, Oscar Salas Vaquero, Jorge Álvarez Alcega
-
Publication number: 20100099899Abstract: A method for extracting internal lipids from wool that is substantially free of lanolin, comprising the use of a fluid under supercritical conditions and an agent that can change the polarity of said fluid, selected from methanol and/or ethanol, is disclosed. According to the operating conditions described, the temperature is between 40° C. and 120° C., and the pressure is between 120 bars and 330 bars. The polarity-changing agent represents between 3% and 15% expressed as volume/volume. The inventive method can be used to obtain internal lipids from wool, one of the most significant components of which are ceramides, which can be used in compositions intended to protect human skin against environmental damage.Type: ApplicationFiled: February 27, 2008Publication date: April 22, 2010Applicants: CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS, CENTRO TECHNOLOGICO GAIKERInventors: Ma Luisa Coderch Negra, Raquel Ramírez Mileo, Meritxell Martí Gelabert, José Luis Parra Juez, Iratxe Garay Peral, Oscar Salas Vaquero, Jorge Álvarez Alcega
-
Patent number: 7138254Abstract: Methods for preparing nanoscale reactions using nucleic acids or proteins are presented. Nucleic acids are captured saturably, yet reversibly, on the internal surface of the reaction chamber, typically a capillary. Excess nucleic acid is removed and the reaction is performed directly within the capillary. Proteins are captured specifically and saturably on the modified inner surface of the reaction chamber, typically a capillary. Excess protein is removed and the reaction is performed directly within the capillary. Devices for effecting the methods of the invention and a system designed advantageously to utilize the methods for high throughput reactions involving nucleic acids or proteins are also provided.Type: GrantFiled: February 7, 2003Date of Patent: November 21, 2006Assignee: GE Healthcare (SV) Corp.Inventors: Stevan Bogdan Jovanovich, Oscar Salas-Solano, Jeng-Thun Li
-
Publication number: 20030224395Abstract: Methods for preparing nanoscale reactions using nucleic acids or proteins are presented. Nucleic acids are captured saturably, yet reversibly, on the internal surface of the reaction chamber, typically a capillary. Excess nucleic acid is removed and the reaction is performed directly within the capillary. Proteins are captured specifically and saturably on the modified inner surface of the reaction chamber, typically a capillary. Excess protein is removed and the reaction is performed directly within the capillary. Devices for effecting the methods of the invention and a system designed advantageously to utilize the methods for high throughput reactions involving nucleic acids or proteins are also provided.Type: ApplicationFiled: February 7, 2003Publication date: December 4, 2003Inventors: Stevan Bogdan Jovanovich, Oscar Salas-Solano, Jeng-Thun Li
-
Patent number: 6476118Abstract: A method of separating a mixture of biopolymers of various lengths using a blend of two linear hydrophilic polymers, particularly polyacrylamides (LPA) or substituted polyacrylamides, one with high weight-average molecular mass and another with low weight-average molecular mass, each present at a low concentration but wherein the concentration of the high weight-average molecular mass LPA is above its entanglement threshold, is disclosed. The matrix is excellent for use in methods of nucleic acid analysis, particularly long read length DNA sequencing.Type: GrantFiled: February 18, 2000Date of Patent: November 5, 2002Assignee: Northeastern UniversityInventors: Barry L. Karger, Lev Kotler, Wolfgang Goetzinger, Haihong Zhou, Zoran Sosic, Oscar Salas-Solano
-
Patent number: 5740878Abstract: A miniaturized single-seater motor-vehicle, in particular for sports and recreative use, comprises two half-frames (2a) identical with each other and substantially extending according to longitudinal vertical planes, each half-frame (2a) being formed of a plurality of sections (9, 11, 12, 13, 14) defining a substantially closed line. The frame (2) supports a motor (19) disposed forwardly of a rear axle (10) and at alowermost position relative to a seat (10). A steering wheel (20) comprises a forward half portion (20b) and a rear half portion (20a) which are asymmetrical relative to an axis of rotation (21). Two side footboards (18) project laterally from the opposite sides of the frame (2) base.Type: GrantFiled: November 27, 1995Date of Patent: April 21, 1998Assignee: Birel S.R.L.Inventor: Oscar Sala